STOCK TITAN

Isoray To Announce Fourth Quarter and Fiscal Year End 2020 Financial Results on September 17, 2020

Isoray, Inc. (ISR) has scheduled a conference call for September 17, 2020, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and fiscal year ending June 30, 2020.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Rhea-AI Summary

Isoray, Inc. (ISR) has scheduled a conference call for September 17, 2020, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and fiscal year ending June 30, 2020. The company is noted for being the sole producer of Cesium-131 brachytherapy seeds, enhancing treatment options in brachytherapy. A press release detailing the financial results will be issued after the market closes on the same day. Investors can participate via phone or a live webcast at this link.

Loading...
Loading translation...

Positive

  • Isoray is the sole producer of Cesium-131 brachytherapy seeds, which expands treatment options.

Negative

  • None.
Argus Session date unavailable
+1.02% session move Open Argus
Details

News Market Reaction – ISR

The recorded move for ISR in the trading session of this news was +1.02%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Conference Call is Thursday, September 17, 2020, at 4:30 p.m. ET/1:30 p.m. PT

RICHLAND, Wash., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it will host a conference call to discuss its financial results for the fourth quarter and fiscal year ended June 30, 2020 on Thursday, September 17, 2020, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2020 after the close of the U.S. stock markets on September 17, 2020. 

To listen to the conference call, please dial (844) 602-0380. For callers outside the U.S., please dial (862) 298-0970.

The conference call will be simultaneously webcast and can be accessed at https://www.webcaster4.com/Webcast/Page/2199/37318 by clicking on the link. The webcast will be available until September 17, 2021 following the conference call.

About Isoray
Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131, commercially known as Cesium Blu, by visiting www.isoray.com. Follow us on LinkedIn and Twitter. Join us on Facebook.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Isoray's conference call scheduled?

Isoray's conference call is set for September 17, 2020, at 4:30 p.m. ET.

What will Isoray discuss in its upcoming conference call?

Isoray will discuss its financial results for the fourth quarter and fiscal year ended June 30, 2020.

How can I access the Isoray conference call?

The conference call can be accessed by dialing (844) 602-0380 for U.S. callers or (862) 298-0970 for international callers.

What is Cesium-131 and why is it important for Isoray?

Cesium-131 is a brachytherapy seed used in cancer treatment, and Isoray is the only producer, making it crucial for their business.

Keep reading